SYNOVIAL IGM RHEUMATOID-FACTOR (RF) SPECIFICITY FOR GENETICALLY-ENGINEERED, CHIMERIC IGG ANTIBODIES (CLGG) IS NOT AFFECTED BY THE METHOD OFB-CELL IMMORTALIZATION

Authors
KWONG T KENNY T ROBBINS DL MORRISON SL BONAGURRA VR
Citation
T. Kwong et al., SYNOVIAL IGM RHEUMATOID-FACTOR (RF) SPECIFICITY FOR GENETICALLY-ENGINEERED, CHIMERIC IGG ANTIBODIES (CLGG) IS NOT AFFECTED BY THE METHOD OFB-CELL IMMORTALIZATION, Arthritis and rheumatism, 38(9), 1995, pp. 82-82
Citations number
NO
Categorie Soggetti
Rheumatology
Journal title
Arthritis and rheumatism → ACNP
ISSN journal
00043591
Volume
38
Issue
9
Year of publication
1995
Supplement
S
Pages
82 - 82
Database
ISI
SICI code
0004-3591(1995)38:9<82:SIR(SF>2.0.ZU;2-M